"Psychotropics and the Elderly: A Critical Public Health Issue." Aging Health, 5(4), pp. 451–452
Financial & competing interests disclosure
Bruce G Pollock receives research support from the National Institute of Health. Within the past 2 years he has been a member of the advisory boards of Forest Laboratories (last meeting was March 2008) and Lundbeck Canada and has served one time as a consultant for Wyeth Pharmaceuticals (October 2008). Bruce G Pollock is currently a faculty member of the Lundbeck International Neuroscience Foundation (LINF).
The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.
Additional information
Funding
Bruce G Pollock receives research support from the National Institute of Health. Within the past 2 years he has been a member of the advisory boards of Forest Laboratories (last meeting was March 2008) and Lundbeck Canada and has served one time as a consultant for Wyeth Pharmaceuticals (October 2008). Bruce G Pollock is currently a faculty member of the Lundbeck International Neuroscience Foundation (LINF).